Tuberculosis of central nervous system and its relationship with pulmonary involvement Source: Eur Respir J 2002; 20: Suppl. 38, 550s Year: 2002
Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension Source: Eur Respir J 2010; 35: 704-705 Year: 2010
Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 792-794 Year: 2009
Interferon-α and the liver monooxygenas system in patients with pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 140s Year: 2006
Cardiovascular autonomic disorders in pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 415s Year: 2004
The adrenergic nervous system as a therapeutic target in pulmonary arterial hypertension: a cautionary tale Source: Eur Respir J 2016; 48: 617-618 Year: 2016
Status of renin-angiotensin-aldosterone system in children with chronic pulmonary diseases. Source: Eur Respir J 2007; 30: Suppl. 51, 390s Year: 2007
The dopaminergic system in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013
Recurrence of pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 504s Year: 2006
Prevalence of pulmonary tuberculosis in spinal tuberculosis patients Source: International Congress 2017 – TB: diagnosis, severity and practical management Year: 2017
Role of surgery in treating of firstly-found destructive pulmonary tuberculosis after ineffective DOTS-therapy Source: Annual Congress 2009 - Treatment of tuberculosis at times of emerging drug resistance Year: 2009
Primary drug resistance in pulmonary tuberculosis Source: Annual Congress 2007 - Specific problems in caring for multidrug-resistant tuberculosis and tuberculosis/HIV cases Year: 2007
Sympathetic nervous system activation is an independent prognostic factor of clinical deterioration in pulmonary arterial hypertensive patients Source: Annual Congress 2009 - Pulmonary arterial hypertension Year: 2009
Chronic pulmonary aspergillosis commonly complicates treated pulmonary tuberculosis with residual cavitation Source: Eur Respir J, 53 (3) 1801184; 10.1183/13993003.01184-2018 Year: 2019
Extra pulmonary manifestation of tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 18s Year: 2006
Disseminated pulmonary TB processes Source: Eur Respir J 2002; 20: Suppl. 38, 364s Year: 2002
Disseminated multiorgan tuberculosis Source: International Congress 2018 – CC4 Tuberculosis Year: 2018
Significance of Bactec system for diagnosis of pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 301s Year: 2006
Atypical aspects of pulmonary tuberculosis Source: Eur Respir J 2006; 28: Suppl. 50, 507s Year: 2006